ModuleMD, a leading innovator in healthcare technology for over 24 years, proudly announces the launch of JOSH, an AI-powered dictation tool designed to revolutionize clinical workflows. ModuleMD has been at the forefront of healthcare innovation, offering specialty-focused Electronic Health Record (EHR) and practice management solutions across Allergy, ENT, and Pulmonology practices....
PictorLabs, a leader in AI-powered virtual staining technology, and Hamamatsu Photonics, a renowned provider of whole slide imaging systems, are excited to announce a strategic partnership to develop cutting-edge applications to advance virtual staining in routine laboratory practices.
Innovations with AI and advanced imaging
PictorLabs, a rapidly growing startup spun off...
IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
IQVIA AI Assistant is a user-friendly,...
BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.
The collaboration aims to leverage BioAI's PredictX platform to develop AI-based models using Arbele's...
Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing cardiovascular disease in general hospitals and clinics.
The financing round was led by Korea Development Bank (KDB), with participation from Woori Venture Partners,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration with Takeda that takes a data-first approach to research and development, with the aim of enhancing Takeda’s oncology research and development efforts.
After an initial collaboration...
ImmunoPrecise Antibodies, ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, proudly announces the clinical progress achieved with rabbit monoclonal antibodies designed and developed using IPA’s proprietary B Cell Select® platform for the clinical-stage company, OncoResponse Inc. This achievement underscores IPA’s leadership as a Contract Research Organization creating high-quality...
Generate:Biomedicines announced a multi-target collaboration with Novartis to discover and develop protein therapeutics across multiple disease areas. The collaboration leverages Generate’s proprietary generative AI platform, “The Generate Platform,” to create potentially first- and best-in-class molecules through AI-based optimization and de novo generation.
The collaboration will combine The Generate Platform, which integrates...
XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug discovery. Upon this launch, XtalPi will offer commercial licenses with flexible terms for industrial and academic scientists to use the software based on their research goals. With...
XpertDox and Blue Fish Pediatrics Join Forces to Streamline Medical Coding, Enhance Clinical Documentation, and Boost Reimbursement Potential
XpertDox, a leader in AI-powered medical coding software, has partnered with Blue Fish Pediatrics, a premier provider of pediatric care in Texas. This partnership aims to transform medical coding by enhancing efficiency, accuracy,...
